Drug intelligence / Profile preview

dexamethasone + camphor + menthol

Development stage: Unknown
Lead developer: Jiangmen Hengjian Pharmaceutical
Modality: Small Molecules
Administration: Topical

Overview

This combination drug includes **dexamethasone acetate**, a synthetic glucocorticoid used for its anti-inflammatory and anti-allergic properties; **camphor**, a topical analgesic and antiseptic; and **menthol**, which provides a cooling sensation to relieve pain and itching. It is used to treat skin conditions such as dermatitis and eczema[1][2].

Brand names: 999 ITCH RELIEF (menthol ointment)
Other names: Compound dexamethasone acetate/camphor/menthol

Targets

GR (Glucocorticoid receptor)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on dexamethasone + camphor + menthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + camphor + menthol.

Explore the full profile